General Information
AstraZeneca D1840M00070
Screening Study to Identify Participants With a High Likelihood of Non-alcoholic Fatty Liver Disease / Non-alcoholic
| Protocol | D1840M00070 |
|---|---|
| Identifier | |
| UID | 709fc4ea-a14f-452a-aba6-10c8b4c1bf14 |
| Status | Done - Archived |
| Phase | Exploratory Study |
| Category | Fatty Liver / Adult |
| Launch Year | 2022 |
| NCT Number | - |
| Created | 2022-05-24 11:13 |
| Last Updated | 2024-08-12 20:45 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2024-05-02 | No |
| Enrollment Open | 2022-08-01 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2022-07-28 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2024-08-07 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | - | No | |
| Coordinator | Valenzuela, Louisito | LValenzuela | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | AstraZeneca Pharmaceuticals |
|---|---|
| Division | AstraZeneca Pharamecuticals |
| Team | AstraZeneca Pharamecuticals LP |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | IQVIA Clinical Trial Payments |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
